Market
Scenario:
Precision medicine refers to medicines developed as
per an individual’s genetic profile that helps as a guide for the prevention,
diagnosis and treatment of diseases. The global precision medicine market was
valued at $38.92 billion in 2015, and is expected to reach $88.64 billion by
2022. Thus the market is expected to perform a growth at a CAGR of 12.48% from
2015 to 2022.
The major market driving factor for precision
medicine are patient’s involvement in personal healthcare, integration of
wireless technologies with portable healthcare devices, and increase in genetic
diseases (due to mutation, UV rays) among others.
The market constraints include potential threat to
personal data, high diagnostic cost as a barrier, potential risk of hardware or
software failure, stringent regulations and standards, lack of awareness about
the possible applications of precision medicine, reimbursement policies and
regulatory framework, limited knowledge about the application of test and
techniques, lack of research and evidences creating hindrances in its
application.
Key
Players for Global Precision Medicine Market:
Abbott Laboratories, Almac Group, Ltd., Asuragen, Inc., Biomérieux Sa, Cepheid Inc., Cetics Healthcare Technologies Gmbh, Ge Healthcare, Glaxosmithkline Plc, Johnson & Johnson, Laboratory Corporation Of America Holdings, Medtronic, Novartis, Pfizer Inc., Qiagen, Biobase Gmbh, Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ab-Biotics Sa, Caris Life Sciences, Healthcore, Inc., Ibm, Innventis, Intel Corporation, Molecular Health Gmbh, Precision For Medicine
Abbott Laboratories, Almac Group, Ltd., Asuragen, Inc., Biomérieux Sa, Cepheid Inc., Cetics Healthcare Technologies Gmbh, Ge Healthcare, Glaxosmithkline Plc, Johnson & Johnson, Laboratory Corporation Of America Holdings, Medtronic, Novartis, Pfizer Inc., Qiagen, Biobase Gmbh, Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ab-Biotics Sa, Caris Life Sciences, Healthcore, Inc., Ibm, Innventis, Intel Corporation, Molecular Health Gmbh, Precision For Medicine
Segments:
Global Precision Medicine market has been segmented on the basis of ecosystem, sub-market, therapeutics and region.
Global Precision Medicine market has been segmented on the basis of ecosystem, sub-market, therapeutics and region.
Regional
Analysis
Globally North America is the largest market for global precision medicine. Europe is the second-largest market for global precision medicine. The near future market for precision medicine will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future.
Globally North America is the largest market for global precision medicine. Europe is the second-largest market for global precision medicine. The near future market for precision medicine will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future.
Browse
Complete 313 Pages Premium Research Report Enabled with Respective Tables and
Figures @ https://www.marketresearchfuture.com/reports/precision-medicine-market-925
Detailed
Table of Contents:
1 Introduction
1.1 Scope Of The Study
1.2 Precision Medicine:
Report Coverage
1.3 Research Methodology
1.3.1 Research
Methodology For The Global Market Study
1.3.2 Global Precision
Medicine: Research Methodology
1.3.3 Key Data Point
Sources
1.4 Report Description
2 Executive Summary
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Overview
3.1 Introduction
3.2 Market Timeline
3.3 Key Participants,
Strategies & Developments
3.3.1 Government Agencies
3.3.2 Academic
Institutions
3.3.3 Device &
Service Providers
3.4 Key Market Strategies
And Developments
3.4.1 Introduction
3.4.2 Partnerships,
Agreements, And Collaborations
3.4.3 Mergers &
Acquisitions
3.4.4 Product Development
And Launch
3.4.5 Business
Expansion/Contracts
3.4.6 Patents, Approvals
And Certifications
3.4.7 Others (Events
& Recognitions)
4 Market Dynamics
4.1
Introduction
4.2
Market Drivers
4.2.1
Patients Involvement In Personal Healthcare
4.2.2
Technologies Driving The Market (E.G. Next-Generation Sequencing Technologies,
Ultra-High Throughput Sequencing)
4.2.3
Increase In Genetic Diseases
4.2.4
Potential For More Targeted Therapies
4.2.5
Integration Of Big Data Healthcare Companies With Pharma & Biotech
Companies
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment